Juniper Pharm Inc (JNP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2002 | 12-2001 | 09-2001 | 06-2001 | 03-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,381 | -15,846 | -11,490 | -8,249 | -3,819 |
| Depreciation Amortization | 165 | 688 | 519 | 337 | 180 |
| Accounts receivable | -160 | 2,106 | 2,038 | 2,292 | 2,380 |
| Accounts payable and accrued liabilities | 726 | -165 | 150 | 198 | 97 |
| Other Working Capital | 74 | 2,298 | 2,486 | 3,899 | 3,104 |
| Other Operating Activity | -566 | -1,248 | -1,824 | -2,277 | -2,435 |
| Operating Cash Flow | $-3,142 | $-12,167 | $-8,121 | $-3,800 | $-494 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -158 | -189 | -38 | -8 | -6 |
| Investing Cash Flow | $-158 | $-189 | $-38 | $-8 | $-6 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 2,985 | 9,038 | 6,101 | 3,122 | 1,491 |
| Dividend Paid | -47 | -202 | -152 | -101 | -51 |
| Financing Cash Flow | $2,938 | $8,836 | $5,949 | $3,021 | $1,441 |
| Exchange Rate Effect | -11 | -14 | 6 | -24 | -20 |
| Beginning Cash Position | 4,061 | 7,595 | 7,595 | 7,595 | 7,595 |
| End Cash Position | 3,688 | 4,061 | 5,389 | 6,783 | 8,516 |
| Net Cash Flow | $-373 | $-3,534 | $-2,205 | $-812 | $921 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,142 | -12,167 | -8,121 | -3,800 | -494 |
| Capital Expenditure | -158 | -189 | -38 | -8 | -6 |
| Free Cash Flow | -3,300 | -12,356 | -8,160 | -3,808 | -500 |